Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations

AIDS Behav. 2013 Sep;17(7):2283-92. doi: 10.1007/s10461-013-0415-2.

Abstract

We present selected theoretical issues regarding conditional economic incentives (CEI) for HIV treatment adherence. High HIV treatment adherence is essential not only to improve individual health for persons living with HIV, but also to reduce transmission. The incentives literature spans several decades and various disciplines, thus we selectively point out useful concepts from economics, psychology and HIV clinical practice to elucidate the complex interaction between socio-economic issues, psychological perspectives and optimal treatment adherence. Appropriately-implemented CEI can help patients improve their adherence to HIV treatment in the short-term, while the incentives are in place. However, more research is needed to uncover mechanisms that can increase habit formation or maintenance effects in the longer-term. We suggest some potentially fruitful avenues for future research in this area, including the use of concepts from self-determination theory. This general framework may have implications for related research among disadvantaged communities with high rates of HIV/AIDS infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy*
  • Acquired Immunodeficiency Syndrome / economics
  • Acquired Immunodeficiency Syndrome / psychology*
  • Anti-HIV Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Monitoring
  • HIV Infections / drug therapy*
  • HIV Infections / economics
  • HIV Infections / psychology*
  • Habits
  • Humans
  • Medication Adherence / psychology*
  • Motivation*
  • Personal Autonomy
  • Randomized Controlled Trials as Topic
  • Socioeconomic Factors*
  • Therapeutics / economics
  • Therapeutics / psychology*
  • Token Economy*
  • Vulnerable Populations

Substances

  • Anti-HIV Agents